XmAb819 / Xencor 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
XmAb819 / Xencor
XmAb819-01, NCT05433142: Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Recruiting
1
95
US
XmAb819
Xencor, Inc.
Clear Cell Renal Cell Carcinoma
04/25
03/27

Download Options